JW Pharmaceutical Corporation (001067.KS) KSC

60,300.00

+300(+0.50%)

Updated at September 26 04:44PM

Currency In KRW

Valuation

Market Cap559.8B
Enterprise Value641.1B
P/E Ratio9.48
PEG Ratio-0.57
Price/Sales Ratio0.65
Price/Book Ratio1.49
Enterprise/Revenue0.72
Enterprise/EBITDA2.28

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.07
Operating Margin0.12

Management Effectiveness

Return On Assets0.08
Return On Equity0.17

Income Statement

Revenue719.38B
Revenue/Share32,012.37
Gross Profit323.5B
EBITDA110.17B
Net Income65.04B
Diluted EPS2,644.47

Balance Sheet

Total Cash53.14B
Total Cash/Share2,289.98
Total Debt79.69B
Total Debt/Equity0.24
Current Ratio1.48
Book Value Per Share14,267.83

Price History

52-Week Change3.79
52-Week High65,600
52-Week Low56,000
Moving Average 50 Days61,156
Moving Average 200 Days61,418.5

Statistics

Average Volume35
Shares Outstanding7.93M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate450
Trailing Annual Dividend Yield2.12
Payout Ratio0.19
Last Split Factor51:50
Last Split DateDecember 27, 2023